APOA1 and autoimmune pancreatitis: Additionally, we evaluated the efficacy of liver-targeted treatments previously assessed in AIP mice, including adeno-associated vector (rAAV)-based gene therapy and an insulin-apolipoprotein AI fusion protein (Ins-ApoAI) [1].